胃食管交界处
化疗
成纤维细胞生长因子受体
癌症研究
癌症
医学
总体生存率
肿瘤科
腺癌
内科学
胃肠病学
成纤维细胞生长因子
受体
出处
期刊：Cancer Discovery
[American Association for Cancer Research]
日期：2021-02-11
卷期号：11 (5): OF3-OF3
被引量：2
标识
DOI：10.1158/2159-8290.cd-nb2021-0312
摘要
Abstract In the phase II FIGHT trial, adding bemarituzumab to chemotherapy led to longer progression-free survival and overall survival in patients with advanced FGFR2b-positive gastric or gastroesophageal junction cancers. However, the agent was also associated with more side effects, including eye problems.
科研通智能强力驱动
Strongly Powered by AbleSci AI
爱静静
寻道图强
乐乐乐乐乐乐
个性的紫菜
都是
不配.
Singularity
kento
Frank
InfoNinja
yyymmma
Raylihuang
MoonFlows
咖啡豆
pcr163
xiaxiao
OCDer
浅尝离白
jyy
科研文献搬运工
皖公网安备34019202002308
